Q00987 [Direct mapping]
E3 ubiquitin-protein ligase Mdm2

GO:0000122 [negative regulation of transcription from RNA polymerase II promoter]
GO:0001568 [blood vessel development]
GO:0001974 [blood vessel remodeling]
GO:0002027 [regulation of heart rate]
GO:0002039 [p53 binding]
GO:0003170 [heart valve development]
GO:0003181 [atrioventricular valve morphogenesis]
GO:0003203 [endocardial cushion morphogenesis]
GO:0003281 [ventricular septum development]
GO:0003283 [atrial septum development]
GO:0004842 [ubiquitin-protein transferase activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005730 [nucleolus]
GO:0005737 [cytoplasm]
GO:0005829 [cytosol]
GO:0005886 [plasma membrane]
GO:0006511 [ubiquitin-dependent protein catabolic process]
GO:0006977 [DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest]
GO:0007089 [traversing start control point of mitotic cell cycle]
GO:0007507 [heart development]
GO:0008097 [5S rRNA binding]
GO:0008270 [zinc ion binding]
GO:0008284 [positive regulation of cell proliferation]
GO:0009636 [response to toxic substance]
GO:0010039 [response to iron ion]
GO:0010468 [regulation of gene expression]
GO:0010628 [positive regulation of gene expression]
GO:0010629 [negative regulation of gene expression]
GO:0010955 [negative regulation of protein processing]
GO:0010977 [negative regulation of neuron projection development]
GO:0016032 [viral process]
GO:0016567 [protein ubiquitination]
GO:0016579 [protein deubiquitination]
GO:0016604 [nuclear body]
GO:0016740 [transferase activity]
GO:0016874 [ligase activity]
GO:0016925 [protein sumoylation]
GO:0018205 [peptidyl-lysine modification]
GO:0019789 [SUMO transferase activity]
GO:0019899 [enzyme binding]
GO:0019904 [protein domain specific binding]
GO:0030666 [endocytic vesicle membrane]
GO:0031625 [ubiquitin protein ligase binding]
GO:0031648 [protein destabilization]
GO:0032026 [response to magnesium ion]
GO:0032436 [positive regulation of proteasomal ubiquitin-dependent protein catabolic process]
GO:0032991 [macromolecular complex]
GO:0034504 [protein localization to nucleus]
GO:0036369 [transcription factor catabolic process]
GO:0042176 [regulation of protein catabolic process]
GO:0042220 [response to cocaine]
GO:0042493 [response to drug]
GO:0042802 [identical protein binding]
GO:0042975 [peroxisome proliferator activated receptor binding]
GO:0043021 [ribonucleoprotein complex binding]
GO:0043066 [negative regulation of apoptotic process]
GO:0043154 [negative regulation of cysteine-type endopeptidase activity involved in apoptotic process]
GO:0043278 [response to morphine]
GO:0043491 [protein kinase B signaling]
GO:0043518 [negative regulation of DNA damage response, signal transduction by p53 class mediator]
GO:0045184 [establishment of protein localization]
GO:0045202 [synapse]
GO:0045472 [response to ether]
GO:0045787 [positive regulation of cell cycle]
GO:0045892 [negative regulation of transcription, DNA-templated]
GO:0045931 [positive regulation of mitotic cell cycle]
GO:0046677 [response to antibiotic]
GO:0046827 [positive regulation of protein export from nucleus]
GO:0046872 [metal ion binding]
GO:0047485 [protein N-terminus binding]
GO:0048545 [response to steroid hormone]
GO:0051603 [proteolysis involved in cellular protein catabolic process]
GO:0051865 [protein autoubiquitination]
GO:0060411 [cardiac septum morphogenesis]
GO:0061630 [ubiquitin protein ligase activity]
GO:0061663 [NEDD8 ligase activity]
GO:0065003 [macromolecular complex assembly]
GO:0070301 [cellular response to hydrogen peroxide]
GO:0071157 [negative regulation of cell cycle arrest]
GO:0071236 [cellular response to antibiotic]
GO:0071301 [cellular response to vitamin B1]
GO:0071310 [cellular response to organic substance]
GO:0071312 [cellular response to alkaloid]
GO:0071363 [cellular response to growth factor stimulus]
GO:0071375 [cellular response to peptide hormone stimulus]
GO:0071391 [cellular response to estrogen stimulus]
GO:0071407 [cellular response to organic cyclic compound]
GO:0071456 [cellular response to hypoxia]
GO:0071480 [cellular response to gamma radiation]
GO:0071494 [cellular response to UV-C]
GO:0072717 [cellular response to actinomycin D]
GO:0097110 [scaffold protein binding]
GO:0097718 [disordered domain specific binding]
GO:1901796 [regulation of signal transduction by p53 class mediator]
GO:1901797 [negative regulation of signal transduction by p53 class mediator]
GO:1902254 [negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator]
GO:1904404 [response to formaldehyde]
GO:1904707 [positive regulation of vascular smooth muscle cell proliferation]
GO:1904754 [positive regulation of vascular associated smooth muscle cell migration]
GO:1990000 [amyloid fibril formation]
GO:1990785 [response to water-immersion restraint stress]

A0A0C4DFR5 [Direct mapping]
E3 ubiquitin-protein ligase Mdm2

GO:0000122 [negative regulation of transcription from RNA polymerase II promoter]
GO:0005634 [nucleus]
GO:0016567 [protein ubiquitination]
GO:0043066 [negative regulation of apoptotic process]
GO:0046872 [metal ion binding]
GO:0071157 [negative regulation of cell cycle arrest]

Q00987 [Direct mapping]
E3 ubiquitin-protein ligase Mdm2

GO:0000122 [negative regulation of transcription from RNA polymerase II promoter]
GO:0002039 [p53 binding]
GO:0004842 [ubiquitin-protein transferase activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005730 [nucleolus]
GO:0005737 [cytoplasm]
GO:0005829 [cytosol]
GO:0005886 [plasma membrane]
GO:0006511 [ubiquitin-dependent protein catabolic process]
GO:0006977 [DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest]
GO:0008097 [5S rRNA binding]
GO:0008270 [zinc ion binding]
GO:0008284 [positive regulation of cell proliferation]
GO:0016032 [viral process]
GO:0016567 [protein ubiquitination]
GO:0016579 [protein deubiquitination]
GO:0016604 [nuclear body]
GO:0016740 [transferase activity]
GO:0016874 [ligase activity]
GO:0016925 [protein sumoylation]
GO:0018205 [peptidyl-lysine modification]
GO:0019789 [SUMO transferase activity]
GO:0019899 [enzyme binding]
GO:0019904 [protein domain specific binding]
GO:0030666 [endocytic vesicle membrane]
GO:0031625 [ubiquitin protein ligase binding]
GO:0031648 [protein destabilization]
GO:0032436 [positive regulation of proteasomal ubiquitin-dependent protein catabolic process]
GO:0032991 [macromolecular complex]
GO:0034504 [protein localization to nucleus]
GO:0036369 [transcription factor catabolic process]
GO:0042176 [regulation of protein catabolic process]
GO:0042802 [identical protein binding]
GO:0043021 [ribonucleoprotein complex binding]
GO:0043066 [negative regulation of apoptotic process]
GO:0043491 [protein kinase B signaling]
GO:0043518 [negative regulation of DNA damage response, signal transduction by p53 class mediator]
GO:0045184 [establishment of protein localization]
GO:0045892 [negative regulation of transcription, DNA-templated]
GO:0045931 [positive regulation of mitotic cell cycle]
GO:0046677 [response to antibiotic]
GO:0046872 [metal ion binding]
GO:0047485 [protein N-terminus binding]
GO:0051603 [proteolysis involved in cellular protein catabolic process]
GO:0051865 [protein autoubiquitination]
GO:0061630 [ubiquitin protein ligase activity]
GO:0061663 [NEDD8 ligase activity]
GO:0065003 [macromolecular complex assembly]
GO:0071157 [negative regulation of cell cycle arrest]
GO:0071456 [cellular response to hypoxia]
GO:0071480 [cellular response to gamma radiation]
GO:0072717 [cellular response to actinomycin D]
GO:0097718 [disordered domain specific binding]
GO:1901796 [regulation of signal transduction by p53 class mediator]
GO:1901797 [negative regulation of signal transduction by p53 class mediator]
GO:1902254 [negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator]
GO:1990000 [amyloid fibril formation]

Q9H4C5 [Direct mapping]
E3 ubiquitin-protein ligase Mdm2; p53-binding protein

GO:0000122 [negative regulation of transcription from RNA polymerase II promoter]
GO:0005634 [nucleus]
GO:0016567 [protein ubiquitination]
GO:0043066 [negative regulation of apoptotic process]
GO:0046872 [metal ion binding]
GO:0071157 [negative regulation of cell cycle arrest]

A7UKX8 [Direct mapping]
E3 ubiquitin-protein ligase Mdm2; Mdm2

GO:0000122 [negative regulation of transcription from RNA polymerase II promoter]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0016567 [protein ubiquitination]
GO:0043066 [negative regulation of apoptotic process]
GO:0071157 [negative regulation of cell cycle arrest]

Q8TE47 [Direct mapping]
E3 ubiquitin-protein ligase Mdm2; MDM2 isoform KB9 protein

GO:0000122 [negative regulation of transcription from RNA polymerase II promoter]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0016567 [protein ubiquitination]
GO:0043066 [negative regulation of apoptotic process]
GO:0071157 [negative regulation of cell cycle arrest]

Q9H4C3 [Direct mapping]
E3 ubiquitin-protein ligase Mdm2; p53 binding protein

GO:0000122 [negative regulation of transcription from RNA polymerase II promoter]
GO:0005634 [nucleus]
GO:0016567 [protein ubiquitination]
GO:0043066 [negative regulation of apoptotic process]
GO:0071157 [negative regulation of cell cycle arrest]

A7UKY0 [Direct mapping]
E3 ubiquitin-protein ligase Mdm2; Mdm2

GO:0000122 [negative regulation of transcription from RNA polymerase II promoter]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005730 [nucleolus]
GO:0006511 [ubiquitin-dependent protein catabolic process]
GO:0016567 [protein ubiquitination]
GO:0043066 [negative regulation of apoptotic process]
GO:0071157 [negative regulation of cell cycle arrest]

F5GWH7 [Direct mapping]
E3 ubiquitin-protein ligase Mdm2

GO:0000122 [negative regulation of transcription from RNA polymerase II promoter]
GO:0016567 [protein ubiquitination]